Stock Events

Stock Events

Theratechnologies

€0.000000

0

+€0.00+0% 00:00 Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TQ8.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Amgen develops therapies in areas similar to Theratechnologies, focusing on serious illnesses including oncology, which competes with Theratechnologies' work in HIV-related cancers.

Gilead Sciences

Gilead Sciences is a direct competitor in the HIV and infectious disease space, offering treatments that could be alternatives to Theratechnologies' products.

Vertex Pharmaceuticals

Vertex Pharmaceuticals competes in creating innovative therapies for serious diseases, potentially overlapping with Theratechnologies' market in metabolic disorders and conditions related to HIV.

Biogen focuses on developing drugs for neurological and neurodegenerative diseases, competing indirectly with Theratechnologies by targeting similar patient demographics with complex conditions.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals competes in the biopharmaceutical field, focusing on innovative treatments that could rival Theratechnologies' products in metabolic diseases and conditions associated with HIV.

Lakefront Biotherapeutics NV

Galapagos NV focuses on developing novel modes of action, which could compete with Theratechnologies in the area of innovative treatments for various diseases, including those related to metabolic and infectious diseases.

AbbVie operates in similar therapeutic areas as Theratechnologies, including HIV, and its broad portfolio in immunology and oncology could present competitive pressures.

Pfizer has a diverse range of products that compete across several of Theratechnologies' interest areas, including treatments for infectious diseases and cancer.

Merck is a global healthcare company that offers products directly competing with Theratechnologies, especially in the fields of infectious diseases and cancer.

Novo Nordisk is a leading company in diabetes and metabolic disorder treatments, areas where Theratechnologies is also aiming to make an impact.

About

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Show more...

CEO

Mr. Paul Lévesque

Employees

103

Country

Canada

ISIN

CA88338H1001

Listings

0 Comments

Share your thoughts

FAQ

What is Theratechnologies stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Theratechnologies stocks are traded under the ticker TQ8.MU.

How many employees does Theratechnologies have?▼

As of July 08, 2026, the company has 103 employees.

In which sector is Theratechnologies located?▼

Theratechnologies operates in the Health & Wellness sector.

When did Theratechnologies complete a stock split?▼

Theratechnologies has not had any recent stock splits.

Where is Theratechnologies headquartered?▼

Theratechnologies is headquartered in Montreal, Canada.